Literature DB >> 21478423

Double effect: a useful rule that alone cannot justify hastening death.

J Andrew Billings1.   

Abstract

The rule of double effect is regularly invoked in ethical discussions about palliative sedation, terminal extubation and other clinical acts that may be viewed as hastening death for imminently dying patients. Unfortunately, the literature tends to employ this useful principle in a fashion suggesting that it offers the final word on the moral acceptability of such medical procedures. In fact, the rule cannot be applied appropriately without invoking moral theories that are not explicit in the rule itself. Four tenets of the rule each require their own ethical justification. A variety of moral theories are relevant to making judgements in a pluralistic society. Much of the rich moral conversation germane to the rule has been reflected in arguments about physician-assisted suicide and voluntary active euthanasia, but the rule itself has limited relevance to these debates, and requires its own moral justifications when applied to other practices that might hasten death.

Entities:  

Mesh:

Year:  2011        PMID: 21478423     DOI: 10.1136/jme.2010.041160

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  4 in total

1.  Murder and euthanasia accusations against physicians.

Authors:  Lewis M Cohen
Journal:  Mayo Clin Proc       Date:  2012-09       Impact factor: 7.616

2.  Lifespan extension and the doctrine of double effect.

Authors:  Laura Capitaine; Katrien Devolder; Guido Pennings
Journal:  Theor Med Bioeth       Date:  2013-06

3.  The ethics of prescription of placebos to patients with major depressive disorder.

Authors:  Shun-Jie Chua; Mark Pitts
Journal:  Chin Med J (Engl)       Date:  2015-06-05       Impact factor: 2.628

4.  Changes in attitudes towards hastened death among Finnish physicians over the past sixteen years.

Authors:  Reetta P Piili; Riina Metsänoja; Heikki Hinkka; Pirkko-Liisa I Kellokumpu-Lehtinen; Juho T Lehto
Journal:  BMC Med Ethics       Date:  2018-05-30       Impact factor: 2.652

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.